Andros Pharmaceuticals Co.,Ltd (TPEX:6917)
38.00
-2.10 (-5.24%)
May 8, 2026, 2:00 PM CST
TPEX:6917 Market Cap
TPEX:6917 has a market cap or net worth of 1.74 billion as of May 8, 2026. Its market cap has increased by 140.76% in one year.
Market Cap
1.74B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
38.00
Market Cap Chart
Since January 12, 2023, TPEX:6917's market cap has increased from 1.11B to 1.74B, an increase of 55.97%. That is a compound annual growth rate of 14.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.74B | 57.41% |
| Dec 31, 2025 | 1.10B | 43.17% |
| Dec 31, 2024 | 770.08M | -30.92% |
| Dec 29, 2023 | 1.11B | 0.19% |
| Jan 12, 2023 | 1.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 2.19B |
| Taiwan Bio Therapeutics | 2.17B |
| Gwo Xi Stem Cell Applied Technology Co. , | 2.06B |
| Greenyn Biotechnology | 1.87B |
| Synbio Tech | 1.87B |
| Anti-Microbial Savior BioteQ | 1.86B |
| TaiRx | 1.81B |
| Great Novel Therapeutics Biotech & Medicals | 1.68B |